MedTrace Logo

Alcohol Interaction Study

NCT01181908 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2017-06-27

No results posted yet for this study

Summary

The purpose of this study is understand the effects of GSK114814 and alcohol in healthy volunteers when taken together.

Conditions

  • Alcoholism

Interventions

DRUG

single dose

Subjects will receive a single dose of GSK1144814 or placebo.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-11
Primary Completion
2009-12-30
Completion
2009-12-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01181908 on ClinicalTrials.gov